Abstract
The medicinal powers of opium poppy-derived extracts now called ‘opioids’ and the importance of vasculature in maintaining life were realized by ancient civilizations. However, the association of the two with each other has emerged in the last decade. Opioid receptors, including the mu opioid receptor (MOR) which mediates opioid analgesia, are present on the endothelium. Analgesic opioids such as morphine and its congeners stimulate growth- and survival promoting signaling directly via MOR and also by co-activating receptor tyrosine kinases for vascular endothelial growth factor receptor 2, platelet-derived growth factor receptor β, etc. in the endothelial cells. Opioid signaling translates into increased tumor angiogenesis, tumor growth, metastases and reduced survival in mice. Additionally, opioids modulate the tumor microenvironment by acting on diverse cellular milieu of the tumor. Increased density of MOR in human tumors as compared to normal tissue, suggests a role for MOR in cancer. Based on experimental studies and MOR expression on human tumors it is critical to examine the role of opioids in cancer progression and survival in patients treated with opioids for severe pain.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- 11C-CFN:
-
11C-carfentanil
- 11C-MeNTI:
-
11C-methylnaltrindole
- cAMP:
-
cyclic adenosine monophosphate
- COX:
-
Cyclooxygenase
- DOR:
-
delta opioid receptor
- GPCRs:
-
G-coupled protein receptors
- GRK:
-
GPCR kinase
- KOR:
-
kappa opioid receptor
- MNTX:
-
methylnaltrexone
- MAPK:
-
mitogen-activated protein kinase
- MOR:
-
mu opioid receptor
- NO:
-
nitric oxide
- NOS:
-
NO synthase
- NOP-R:
-
nociceptin/Orphanin FQ receptor
- NSCLC:
-
non-small cell lung cancer
- PDGF:
-
platelet-derived growth factor
- PDGFR-b:
-
platelet-derived growth factor receptor-β
- PET:
-
Positron emission tomography
- POMC:
-
proopiomelanocortin
- PGE2:
-
prostaglandin E2
- Akt:
-
protein kinase B
- RAVE:
-
Relative activity versus endocytosis
- STAT-3:
-
signal transducer and activator of transcription-3
- SCLC:
-
small cell lung cancer
- S1P3R:
-
sphingosine-1 phosphate receptor
- VEGF:
-
vascular endothelial growth factor
- VEGFR2, Flk1:
-
VEGF receptor-2
References
Arerangaiah R, Chalasani N, Udager AM, Weber ML, Manivel JC, Griffin RJ, Song CW, Gupta K (2007) Opioids induce renal abnormalities in tumor-bearing mice. Nephron Exp Nephrol 105:e80–89. doi:10.1159/000098564
Bartoli M, Platt D, Lemtalsi T, Gu X, Brooks SE, Marrero MB, Caldwell RB (2003) VEGF differentially activates STAT3 in microvascular endothelial cells. FASEB J 17:1562–1564. doi:10.1096/fj.02-1084fje
Birnbaum Y, Ye Y, Rosanio S, Tavackoli S, Hu ZY, Schwarz ER, Uretsky BF (2005) Prostaglandins mediate the cardioprotective effects of atorvastatin against ischemia-reperfusion injury. Cardiovasc Res 65:345–355. doi:10.1016/j.cardiores.2004.10.018
Borner C, Kraus J, Schroder H, Ammer H, Hollt V (2004) Transcriptional regulation of the human mu-opioid receptor gene by interleukin-6. Mol Pharmacol 66:1719–1726. doi:10.1124/mol.104.003806
Chang SH, Liu CH, Conway R, Han DK, Nithipatikom K, Trifan OC, Lane TF, Hla T (2004) Role of prostaglandin e2-dependent angiogenic switch in cyclooxygenase 2-induced breast cancer progression. Proc Natl Acad Sci U S A 101:591–596. doi:10.1073/pnas.2535911100
Chen C, Farooqui M, Gupta K (2006) Morphine stimulates vascular endothelial growth factor-like signaling in mouse retinal endothelial cells. Curr Neurovasc Res 3:171–180
Ecimovic P, Murray D, Doran P, McDonald J, Lambert DG, Buggy DJ (2011) Direct effect of morphine on breast cancer cell function in vitro: role of the net1 gene. Br J Anaesth 107:916–923. doi:10.1093/bja/aer259
Exadaktylos AK, Buggy DJ, Moriarty DC, Mascha E, Sessler DI (2006) Can anesthetic technique for primary breast cancer surgery affect recurrence or metastasis? Anesthesiology 105:660–664
Farooqui M, Li Y, Rogers T, Poonawala T, Griffin RJ, Song CW, Gupta K (2007) COX-2 inhibitor celecoxib prevents chronic morphine-induced promotion of angiogenesis, tumour growth, metastasis and mortality, without compromising analgesia. Br J Cancer 97:1523–1531. doi:10.1038/sj.bjc.6604057
Fichna J, Janecka A (2004) Opioid peptides in cancer. Cancer Metastasis Rev 23:351–366. doi:10.1023/B:CANC.0000031773.46458.63
Fimiani C, Mattocks D, Cavani F, Salzet M, Deutsch DG, Pryor S, Bilfinger TV, Stefano GB (1999) Morphine and anandamide stimulate intracellular calcium transients in human arterial endothelial cells: coupling to nitric oxide release. Cell Signal 11:189–193
Fujioka N, Nguyen J, Chen C, Li Y, Pasrija T, Niehans G, Johnson KN, Gupta V, Kratzke RA, Gupta K (2011) Morphine-induced epidermal growth factor pathway activation in non-small cell lung cancer. Anesth Analg 113:1353–1364. doi:ANE.0b013e318232b35a [pii] 10.1213/ANE.0b013e318232b35a
Gomez-Vazquez ME, Hernandez-Salazar E, Novelo-Otanez JD, Cabrera-Pivaral CE, Davalos-Rodriguez IP, Salazar-Paramo M (2012) Effect of endovenous morphine vs. ketorolac on proinflammatory cytokines during postoperative analgesia in laparoscopic cholecystectomy. Cir Cir 80:56–62
Griffin RJ, Williams BW, Wild R, Cherrington JM, Park H, Song CW (2002) Simultaneous inhibition of the receptor kinase activity of vascular endothelial, fibroblast, and platelet-derived growth factors suppresses tumor growth and enhances tumor radiation response. Cancer Res 62:1702–1706
Gupta K, Kshirsagar S, Chang L, Schwartz R, Law PY, Yee D, Hebbel RP (2002) Morphine stimulates angiogenesis by activating proangiogenic and survival-promoting signaling and promotes breast tumor growth. Cancer Res 62:4491–4498
Gupta M, Yunfang L, Gupta K (2007) Opioids as promoters and regulators of angiogenesis. In: Maragoudakis ME, Papadimitriou E (eds) Angiogenesis: basic science and clinical applications. Transworld Research Network, Kerala, pp 303–317
Hood JD, Meininger CJ, Ziche M, Granger HJ (1998) VEGF upregulates ecNOS message, protein, and NO production in human endothelial cells. Am J Physiol 274:H1054–H1058
Hou YN, Vlaskovska M, Cebers G, Kasakov L, Liljequist S, Terenius L (1996) A mu-receptor opioid agonist induces AP-1 and NF-kappa B transcription factor activity in primary cultures of rat cortical neurons. Neurosci Lett 212:159–162
Julius D, Basbaum AI (2001) Molecular mechanisms of nociception. Nature 413:203–210. doi:10.1038/35093019
Leahy KM, Ornberg RL, Wang Y, Zweifel BS, Koki AT, Masferrer JL (2002) Cyclooxygenase-2 inhibition by celecoxib reduces proliferation and induces apoptosis in angiogenic endothelial cells in vivo. Cancer Res 62:625–631
Lennon FE, Mirzapoiazova T, Mambetsariev B, Salgia R, Moss J, Singleton PA (2012) Overexpression of the mu-opioid receptor in human non-small cell lung cancer promotes akt and mtor activation, tumor growth, and metastasis. Anesthesiology. doi:10.1097/ALN.0b013e31824babe2
Leo S, Nuydens R, Meert TF (2009) Opioid-induced proliferation of vascular endothelial cells. J Pain Res 2:59–66
Luk K, Boatman S, Johnson KN, Dudek OA, Ristau N, Vang D, Nguyen J, Gupta K (2012) Influence of morphine on pericyte-endothelial interaction: implications for antiangiogenic therapy. J Oncol 2012:458385. doi:10.1155/2012/458385
Madar I, Bencherif B, Lever J, Heitmiller RF, Yang SC, Brock M, Brahmer J, Ravert H, Dannals R, Frost JJ (2007) Imaging delta- and mu-opioid receptors by pet in lung carcinoma patients. J Nucl Med 48:207–213
Malmberg AB, Yaksh TL (1992) Hyperalgesia mediated by spinal glutamate or substance p receptor blocked by spinal cyclooxygenase inhibition. Science 257:1276–1279
Manning BM, Hebbel RP, Gupta K, Haynes CL (2012) Carbon-fiber microelectrode amperometry reveals sickle-cell-induced inflammation and chronic morphine effects on single mast cells. ACS Chem Biol 7:543–551. doi:10.1021/cb200347q
Mathew B, Lennon FE, Siegler J, Mirzapoiazova T, Mambetsariev N, Sammani S, Gerhold LM, LaRiviere PJ, Chen CT, Garcia JG, Salgia R, Moss J, Singleton PA (2011) The novel role of the mu opioid receptor in lung cancer progression: a laboratory investigation. Anesth Analg 112:558–567. doi:ANE.0b013e31820568af [pii] 10.1213/ANE.0b013e31820568af
Merighi S, Gessi S, Varani K, Fazzi D, Mirandola P, Borea PA (2012) Cannabinoid CB(2) receptor attenuates morphine-induced inflammatory responses in activated microglial cells. Br J Pharmacol 166:2371–2385. doi:10.1111/j.1476-5381.2012.01948.x
Nedelec E, Abid A, Cipolletta C, Presle N, Terlain B, Netter P, Jouzeau J (2001) Stimulation of cyclooxygenase-2-activity by nitric oxide-derived species in rat chondrocyte: lack of contribution to loss of cartilage anabolism. Biochem Pharmacol 61:965–978
Nylund G, Pettersson A, Bengtsson C, Khorram-Manesh A, Nordgren S, Delbro DS (2008) Functional expression of mu-opioid receptors in the human colon cancer cell line, HT-29, and their localization in human colon. Dig Dis Sci 53:461–466. doi:10.1007/s10620-007-9897-y
Onoprishvili I, Simon EJ (2007) Chronic morphine treatment up-regulates mu opioid receptor binding in cells lacking filamin A. Brain Res 1177:9–18. doi:10.1016/j.brainres.2007.08.020
Pol O (2007) The involvement of the nitric oxide in the effects and expression of opioid receptors during peripheral inflammation. Curr Med Chem 14:1945–1955
Pol O, Sasaki M, Jimenez N, Dawson VL, Dawson TM, Puig MM (2005) The involvement of nitric oxide in the enhanced expression of mu-opioid receptors during intestinal inflammation in mice. Br J Pharmacol 145:758–766. doi:10.1038/sj.bjp. 0706227
Poonawala T, Levay-Young BK, Hebbel RP, Gupta K (2005) Opioids heal ischemic wounds in the rat. Wound Repair Regen 13:165–174. doi:10.1111/j.1067-1927.2005.130207.x
Prevot V, Rialas CM, Croix D, Salzet M, Dupouy JP, Poulain P, Beauvillain JC, Stefano GB (1998) Morphine and anandamide coupling to nitric oxide stimulates GnRH and CRF release from rat median eminence: neurovascular regulation. Brain Res 790:236–244
Ribatti D, Crivellato E (2011) Mast cells, angiogenesis and cancer. In: Gilfillan AM, Metcalfe DD (eds). Mast Cell Biology: contemporary and emerging topics. Landes Bioscience and Springer Science + Business Media, Austin, pp 270–288
Rittner HL, Labuz D, Richter JF, Brack A, Schafer M, Stein C, Mousa SA (2007) CXCR1/2 ligands induce p38 MAPK-dependent translocation and release of opioid peptides from primary granules in vitro and in vivo. Brain Behav Immun 21:1021–1032. doi:10.1016/j.bbi.2007.05.002
Sacerdote P (2007) Immune cell-derived opioid peptides: back to the future. Brain Behav Immun 21:1019–1020. doi:10.1016/j.bbi.2007.06.006
Salvemini D, Misko TP, Masferrer JL, Seibert K, Currie MG, Needleman P (1993) Nitric oxide activates cyclooxygenase enzymes. Proc Natl Acad Sci U S A 90:7240–7244
Salvemini D, Seibert K, Masferrer JL, Misko TP, Currie MG, Needleman P (1994) Endogenous nitric oxide enhances prostaglandin production in a model of renal inflammation. J Clin Invest 93:1940–1947. doi:10.1172/JCI117185
Samad TA, Moore KA, Sapirstein A, Billet S, Allchorne A, Poole S, Bonventre JV, Woolf CJ (2001) Interleukin-1beta-mediated induction of Cox-2 in the CNS contributes to inflammatory pain hypersensitivity. Nature 410:471–475. doi:10.1038/35068566
Sanchez-Simon FM, Ledo AS, Arevalo R, Rodriguez RE (2012) New insights into opioid regulatory pathways: influence of opioids on Wnt1 expression in zebrafish embryos. Neuroscience 200:237–247. doi:10.1016/j.neuroscience.2011.10.026
Singleton PA, Lingen MW, Fekete MJ, Garcia JG, Moss J (2006) Methylnaltrexone inhibits opiate and VEGF-induced angiogenesis: role of receptor transactivation. Microvasc Res 72:3–11. doi:10.1016/j.mvr.2006.04.004
Singleton PA, Moreno-Vinasco L, Sammani S, Wanderling SL, Moss J, Garcia JG (2007) Attenuation of vascular permeability by methylnaltrexone: role of mOP-R and S1P3 transactivation. Am J Respir Cell Mol Biol 37:222–231. doi:10.1165/rcmb.2006-0327OC
Stefano GB, Hartman A, Bilfinger TV, Magazine HI, Liu Y, Casares F, Goligorsky MS (1995) Presence of the mu3 opiate receptor in endothelial cells: coupling to nitric oxide production and vasodilation. J Biol Chem 270:30290–30293
Stefano GB, Salzet M, Magazine HI, Bilfinger TV (1998) Antagonism of LPS and IFN-gamma induction of iNOS in human saphenous vein endothelium by morphine and anandamide by nitric oxide inhibition of adenylate cyclase. J Cardiovasc Pharmacol 31:813–820
Stein C, Schafer M, Machelska H (2003) Attacking pain at its source: new perspectives on opioids. Nat Med 9:1003–1008. doi:10.1038/nm908
Stephenson EJ, Gupta K (2006) Existence and modus operandii of opioid receptors in endothelium. In: Aird W (ed) The endothelium: a comprehensive reference. Cambridge University Press, Cambridge, MA, pp 451–460
Suzuki S, Chuang LF, Doi RH, Chuang RY (2003) Morphine suppresses lymphocyte apoptosis by blocking p53-mediated death signaling. Biochem Biophys Res Commun 308:802–808
Ustun F, Durmus-Altun G, Altaner S, Tuncbilek N, Uzal C, Berkarda S (2011) Evaluation of morphine effect on tumour angiogenesis in mouse breast tumour model, EATC. Med Oncol 28:1264–1272. doi:10.1007/s12032-010-9573-5
Weber ML, Vang D, Velho PE, Gupta P, Crosson JT, Hebbel RP, Gupta K (2012) Morphine promotes renal pathology in sickle mice. Int J Nephrol Renovasc Dis 5:109–118
Wen H, Lu Y, Yao H, Buch S (2011) Morphine induces expression of platelet-derived growth factor in human brain microvascular endothelial cells: implication for vascular permeability. PLoS One 6:e21707. doi:10.1371/journal.pone.0021707
Westly HJ, Kleiss AJ, Kelley KW, Wong PK, Yuen PH (1986) Newcastle disease virus-infected splenocytes express the proopiomelanocortin gene. J Exp Med 163:1589–1594
Wong CS, Hsu MM, Chou R, Chou YY, Tung CS (2000) Intrathecal cyclooxygenase inhibitor administration attenuates morphine antinociceptive tolerance in rats. Br J Anaesth 85:747–751
Yuen JW, So IY, Kam AY, Wong YH (2004) Regulation of STAT3 by mu-opioid receptors in human neuroblastoma SH-SY5Y cells. Neuroreport 15:1431–1435
Acknowledgements
We thank Mihir Gupta and Hemant Kumar for assistance with figures and Ms Carol Taubert for the artwork and word processing. This work was funded by NIH grants, RO1 HL68802, HL103773, and CA109582.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Gupta, K. (2013). Iatrogenic Angiogenesis. In: Parat, MO. (eds) Morphine and Metastasis. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-5678-6_5
Download citation
DOI: https://doi.org/10.1007/978-94-007-5678-6_5
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-007-5677-9
Online ISBN: 978-94-007-5678-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)